ABSTRACT
Ventilatory thresholds (VT1 and VT2) are critical in exercise prescription and athletic training, delineating the transitions from aerobic to anaerobic metabolism. More specifically, VT1 signifies the onset of lactate accumulation whilst VT2 signifies the onset of metabolic acidosis. Accurate determination of these thresholds is vital for optimizing training intensity. Fractal correlation properties of heart rate variability (HRV), particularly the short-term scaling exponent alpha 1 of Detrended Fluctuation Analysis (DFA-α1), have demonstrated potential for this purpose. This study validates the accuracy of commercial ventilatory threshold estimation algorithm (VT-algorithm) developed by Kubios. The VT-algorithm employs instantaneous heart rate (HR) relative to HR reserve and respiratory rate (RF), along with the DFA-α1. Sixty-four physically active participants underwent an incremental cardiopulmonary exercise test (CPET) with inter-beat interval (RR) measurements. DFA-α1 and the Kubios VT-algorithm were used to assess HR and oxygen uptake (VO2) at ventilatory thresholds. On average VO2 at true VT, DFA-α1, and VT-algorithm derived ventilatory thresholds were 1.74, 2.00 and 1.89 l/min (VT1) and 2.40, 2.41 and 2.40 l/min (VT2), respectively. Correspondingly, average HRs at the true VT, DFA-α1, and VT-algorithm thresholds were 141, 151 and 142 bpm (VT1) and 169, 168 and 170 bpm (VT2), respectively. When compared to the true thresholds, Bland-Altman error statistics (bias ± standard deviation of error) for the DFA-α1 thresholds were -0.26±0.41 l/min or -10±16 bpm at VT1 and 0.00±0.34 l/min or 1±10 bpm at VT2, whereas the VT-algorithm errors were - 0.15±0.28 l/min or -1±11 bpm at VT1 and 0.01±0.20 l/min or -1±7 bpm at VT2. HRV based VT determination algorithms accurately estimate ventilatory thresholds, offering insights into training zones, internal loading, and metabolic transitions during exercise without the need of laboratory equipment. The Kubios VT-algorithm, which incorporates instantaneous HR and RF along with DFA-α1, provided higher accuracy for VO2 and HR values for both VT1 and VT2.
Competing Interest Statement
Tarvainen MP and Lipponen JA are shareholders of a company (Kubios) that designs heart rate variability analysis software. Other co-authors have nothing to declare.
Funding Statement
This study has been funded with an award supported by the European foundation for the study of diabetes (EFSD), Juvenile Diabetes Research Foundation (JDRF) and Eli Lilly and Company (Lilly) as well as by the Finnish Diabetes Research Foundation. JAL was funded by the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding 5101137 and 507T044.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Northern Savo Hospital District in Kuopio, Finland gave ethical approval for this work (484/13.00.00/2017 and 409/13.02.00/2019).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data produced in the present study are available upon reasonable request to the authors.
